tiprankstipranks
Corcept Therapeutics Inc. (DE:HTD)
FRANKFURT:HTD
Holding DE:HTD?
Track your performance easily

Corcept Therapeutics (HTD) Financial Statements

2 Followers

Corcept Therapeutics Financial Overview

Corcept Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Corcept Therapeutics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is €0.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 182.55M$ 163.80M$ 146.81M$ 135.41M$ 123.60M
Gross Profit$ 179.68M$ 161.27M$ 144.27M$ 133.53M$ 121.96M
EBIT$ 52.91M$ 41.59M$ 34.99M$ 31.67M$ 36.38M
EBITDA$ 53.41M$ 41.79M$ 35.17M$ 32.30M$ 36.67M
Net Income Common Stockholders$ 46.69M$ 35.12M$ 27.51M$ 31.16M$ 31.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 380.34M$ 473.16M$ 410.76M$ 368.22M$ 355.23M
Total Assets$ 784.26M$ 714.55M$ 655.93M$ 621.52M$ 594.02M
Total Debt$ 6.79M$ 5.67M$ 76.00K$ 151.00K$ 225.00K
Net Debt$ -373.55M$ -467.49M$ -410.69M$ -368.07M$ -355.00M
Total Liabilities$ 145.42M$ 118.31M$ 108.07M$ 114.81M$ 132.34M
Stockholders Equity$ 638.84M$ 596.24M$ 547.86M$ 506.70M$ 461.68M
Cash Flow-
Free Cash Flow$ 72.19M$ 40.77M$ 23.76M$ 5.89M$ 52.87M
Operating Cash Flow$ 73.83M$ 41.18M$ 23.76M$ 5.89M$ 52.91M
Investing Cash Flow$ -44.04M$ -60.19M$ -9.01M$ 17.10M$ -109.57M
Financing Cash Flow$ -21.09M$ -2.15M$ -543.00K$ 766.00K$ -3.92M
Currency in USD

Corcept Therapeutics Earnings and Revenue History

Corcept Therapeutics Debt to Assets

Corcept Therapeutics Cash Flow

Corcept Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis